These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6360050)
21. Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin. Steerenberg PA; Vendrik CP; de Jong WH; de Groot G; Fichtinger-Schepman AM; Scheefhals AP; Schornagel JH Cancer Chemother Pharmacol; 1988; 22(1):51-7. PubMed ID: 3293840 [TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of l-OHP in mice. Mathé G; Kidani Y; Noji M; Maral R; Bourut C; Chenu E Cancer Lett; 1985 Jun; 27(2):135-43. PubMed ID: 4039973 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821 [TBL] [Abstract][Full Text] [Related]
24. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines. Yoshida M; Khokhar AR; Siddik ZH Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726 [TBL] [Abstract][Full Text] [Related]
25. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo. Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375 [TBL] [Abstract][Full Text] [Related]
26. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M; Balázová E; Ujházy V Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of platinum complexes of 2-aminomethylpyrrolidine derivatives for use as carrier ligands and their antitumor activities. Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):930-5. PubMed ID: 2379286 [TBL] [Abstract][Full Text] [Related]
28. [Acute and subacute toxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in laboratory rodents]. Härtl A; Güttner J; Horn U; Jelinek F; Stöckel U; Schröer HP; Hoffmann H Arch Geschwulstforsch; 1989; 59(4):239-44. PubMed ID: 2640563 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964 [TBL] [Abstract][Full Text] [Related]
30. Improve the anticancer potency of the platinum(II) complexes through functionalized leaving group. Zhao J; Wang D; Xu G; Gou S J Inorg Biochem; 2017 Oct; 175():20-28. PubMed ID: 28689065 [TBL] [Abstract][Full Text] [Related]
31. Platinum complexes in cancer chemotherapy. Antibiot Chemother (1971); 1978; 23():99-112. PubMed ID: 348089 [TBL] [Abstract][Full Text] [Related]
32. Trans-platinum complexes as anticancer drugs: recent developments and future prospects. Radulovic S; Tesic Z; Manic S Curr Med Chem; 2002 Sep; 9(17):1611-8. PubMed ID: 12171556 [TBL] [Abstract][Full Text] [Related]
33. In vitro effect of Pt and Pd mercaptopyridine complexes. Carrara M; Berti T; D'Ancona S; Cherchi V; Sindellari L Anticancer Res; 1997; 17(2A):975-80. PubMed ID: 9137437 [TBL] [Abstract][Full Text] [Related]
34. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175 [TBL] [Abstract][Full Text] [Related]
35. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells. Micetich KC; Barnes D; Erickson LC Cancer Res; 1985 Sep; 45(9):4043-7. PubMed ID: 3896476 [TBL] [Abstract][Full Text] [Related]
36. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335 [TBL] [Abstract][Full Text] [Related]
37. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266 [TBL] [Abstract][Full Text] [Related]
38. In vivo and in vitro effectivity of some platinum complexes. Balázová E; Hrubisko M; Ujházy V Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026 [TBL] [Abstract][Full Text] [Related]
39. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane. Leopold WR; Batzinger RP; Miller EC; Miller JA; Earhart RH Cancer Res; 1981 Nov; 41(11 Pt 1):4368-77. PubMed ID: 7030475 [TBL] [Abstract][Full Text] [Related]
40. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes. Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]